New and Special Drug
-

Bimzelx (Bimekizumab) – Psoriasis | HongKong DengYue Medicine
-

Xgeva (Denosumab) – GCTB | HongKong DengYue Medicine
-

Caprelsa (Vandetanib) – MTC | HongKong DengYue Medicine
-

Romlusevimab – COVID-19 | HongKong DengYue Medicine
-

Zytiga (Abiraterone Acetate) – mCRPC/mCSPC | HongKong DengYue Medicine
-

Ocrevus (Ocrelizumab) – RMS/PPMS | HongKong DengYue Medicine
-

Valcyte (Valganciclovir) – CMV | HongKong DengYue Medicine
-

Mektovi (Binimetinib) – Melanoma | HongKong DengYue Medicine
-

Supect (Radotinib) – Ph+ CML | HongKong DengYue Medicine
-

Hernexeos (Zongertinib) – NSCLC | HongKong DengYue Medicine
-

Turalio (Pexidartinib Capsules) – TGCT | HongKong DengYue Medicine
-

Sishujing (Anrecfen Injection) – CKD-aP | HongKong DengYue Medicine
-

Shuqi (Troxipide) – Gastritis | HongKong DengYue Medicine
-

Nefecon (Budesonide) – IgAN | HongKong DengYue Medicine
-

Ryoncil (Amimestrocel Injection) – SR-aGVHD | HongKong DengYue Medicine
















